glp-1 and alcohol use receptor agonists may protect the liver during consumption GLP-1 Alcohol Use Reduction: Can

2021, pp

Not every patient needs GLP-1 injections, and not every patient is a candidate

Glucagon-like peptide-1 (GLP-1) receptor agonists are a class of medications primarily prescribed for the management of type 2 diabetes mellitus and, more recently, for weight management in adults with obesity or overweight with weight-related comorbidities

Last week, drugmaker Eli Lilly announced results from a late-stage diabetes trial showing that its daily GLP-1 pill orforglipron significantly reduced A1C (a measure of blood sugar) and body weight compared with placebo (a sham pill)

The drugmakers that make Zepbound and Wegovy sell the medicines at a discount to people who pay out of pocket instead of using insurance

We also translate the cardiovascular story into human termswhy some large trials found fewer heart attacks and strokes and give a reality-check on the brain research so you know whats hopeful and whats hype